EP
DNA icon

Essential Partners’s Ginkgo Bioworks DNA Stock Holding History

Essential Partners’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$975 Sell
76
-385
-84% -$3.14K ﹤0.01% 2195
2026
Q2 		$4.57K Sell
461
-2,584
-85% -$21.6K ﹤0.01% 1587
2026
Q1 		$18.7K Buy
3,045
+2,996
+6,114% +$24.9K 0.01% 953
2025
Q4 		$407 Buy
49
+8
+20% +$86 ﹤0.01% 2274
2025
Q3 		$598 Buy
41
+1
+3% +$12 ﹤0.01% 2163
2025
Q2 		$450 Buy
+40
New +$310 ﹤0.01% 1731

Other funds holding DNA

QFMHK
Q Fund Management (Hong Kong) Hong Kong $104M AUM 789.73% 1-Year Est. Return
BSWM
Boston Standard Wealth Management Winchester, Massachusetts $696M AUM 8.98% 1-Year Est. Return
TWM
TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $320M AUM 23.25% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Essential Partners's DNA Position: Q3 2026 in Review

Essential Partners reduced its Ginkgo Bioworks (DNA) stake by 84% in Q3 2026, selling an estimated $3.14K and leaving 76 shares worth $975. The position accounts for ﹤0.01% of the portfolio, ranked #2195.

Essential Partners first reported a position in DNA in Q2 2025 and has held it in 6 quarters since. The position peaked at $18.7K in Q1 2026. 9 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Essential Partners held 76 shares of Ginkgo Bioworks worth $975 as of Q3 2026.
  • Essential Partners sold 385 Ginkgo Bioworks shares in Q3 2026, an estimated $3.14K.
  • Ginkgo Bioworks made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2195 holding.
  • Essential Partners first reported a position in Ginkgo Bioworks in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Ginkgo Bioworks position peaked at $18.7K in Q1 2026.
  • 9 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.